Latest Articles

Predicting HPV+ Oropharyngeal Cancer Recurrence With Novel Biomarker
BY ALLIE STRICKLER
There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.
Antidiabetic Agent Linked to Increased Risk of Bladder Cancer
BY ALLIE CASEY
The FDA recently issued a warning that a type of medicine used to treat Type 2 diabetes may increase a person's risk for developing bladder cancer.
Program Opens to Expand Patient Access to Niraparib for Ovarian Cancer
BY BRIELLE URCIUOLI
An expanded access program (EAP) was just opened up for ceratain patients with ovarian cancer to receive niraparib.
Pivotal Trial Finds That Imbruvica Shows Benefit in CLL and SLL
BY DANIELLE BUCCO
Imbruvica (ibrutinib) improved survival for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL), according to study results that were recently presented.
Individualized Treatment Is Needed for mCRC Subset
BY GREG KENNELTY
CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.
The Lawyer
BY DOMNA ANTONIADIS
Tweet Chat: The Community of Cancer and The Language They Use
BY JEN SOTHAM
On January 19, we'll be co-hosting a tweet chat with Oncology Nursing News and Jen Sotham about the phrases and language used by the cancer community. Join us at 9 p.m. EST with the hashtag #CureConnect 
Irregular Menstrual Cycles May Offer Insight to Ovarian Cancer Risk
BY BRIELLE URCIUOLI
A recent study examined the relationship between polycystic ovarian syndrome, long or irregular periods and ovarian cancer risk.